Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Sarcoma × fludarabine × Clear all

Phase

Status

Sponsor Class

OTHER 5 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 31 Leukemia, Lymphocytic, Chronic, B-Cell 24 Multiple Myeloma 23 Recurrence 21 Lymphoma, Non-Hodgkin 21 Lymphoma 20 Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell 12 Leukemia 12 Carcinoma, Non-Small-Cell Lung 12 Lymphoma, Follicular 11 Stomach Neoplasms 9 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Myelodysplastic Syndromes 6 Carcinoma, Renal Cell 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Lymphoma, B-Cell, Marginal Zone 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Myasthenia Gravis 4 Melanoma 4 Liposarcoma, Myxoid 4

Interventions

Doxorubicin 30 Gemcitabine 11 pembrolizumab 10 pazopanib 8 Trabectedin 8 Irinotecan 8 eribulin 7 olaratumab 6 Cyclophosphamide 6 Injections 5 Docetaxel 5 ridaforolimus 4 anlotinib 4 Nivolumab 4 Ifosfamide 4 Bevacizumab 4 tazemetostat 3 belinostat 3 Temozolomide 3 TH 302 3 Paclitaxel 3 Ipilimumab 3 Fluorouracil 3 Epirubicin 3 Drug Therapy 3 DOXO-EMCH 3 Carboplatin 3 trastuzumab deruxtecan 2 toripalimab 2 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01343043 2021-06-30

NY-ESO-1

GlaxoSmithKline

Phase 1 Completed

50 enrolled 17 charts

Neoplasm Metastasis, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡